JP4717110B2 - 生体適合性が改善されたカルニチンを含有する腹膜透析液 - Google Patents

生体適合性が改善されたカルニチンを含有する腹膜透析液 Download PDF

Info

Publication number
JP4717110B2
JP4717110B2 JP2008500161A JP2008500161A JP4717110B2 JP 4717110 B2 JP4717110 B2 JP 4717110B2 JP 2008500161 A JP2008500161 A JP 2008500161A JP 2008500161 A JP2008500161 A JP 2008500161A JP 4717110 B2 JP4717110 B2 JP 4717110B2
Authority
JP
Japan
Prior art keywords
carnitine
glucose
solution
pds
peritoneal dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2008500161A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008532601A (ja
JP2008532601A5 (enExample
Inventor
アルドゥイーノ・アルドゥイーニ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of JP2008532601A publication Critical patent/JP2008532601A/ja
Publication of JP2008532601A5 publication Critical patent/JP2008532601A5/ja
Application granted granted Critical
Publication of JP4717110B2 publication Critical patent/JP4717110B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/20Elemental chlorine; Inorganic compounds releasing chlorine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
JP2008500161A 2005-03-10 2006-02-22 生体適合性が改善されたカルニチンを含有する腹膜透析液 Active JP4717110B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITPCT/IT2005/000130 2005-03-10
IT2005000130 2005-03-10
PCT/EP2006/060162 WO2006094900A1 (en) 2005-03-10 2006-02-22 Carnitine-containing peritoneal dialysis solution having improved biocompatibility

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010146533A Division JP5366894B2 (ja) 2005-03-10 2010-06-28 生体適合性が改善されたカルニチンを含有する腹膜透析液

Publications (3)

Publication Number Publication Date
JP2008532601A JP2008532601A (ja) 2008-08-21
JP2008532601A5 JP2008532601A5 (enExample) 2009-04-09
JP4717110B2 true JP4717110B2 (ja) 2011-07-06

Family

ID=35159907

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008500161A Active JP4717110B2 (ja) 2005-03-10 2006-02-22 生体適合性が改善されたカルニチンを含有する腹膜透析液
JP2010146533A Active JP5366894B2 (ja) 2005-03-10 2010-06-28 生体適合性が改善されたカルニチンを含有する腹膜透析液

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010146533A Active JP5366894B2 (ja) 2005-03-10 2010-06-28 生体適合性が改善されたカルニチンを含有する腹膜透析液

Country Status (19)

Country Link
US (1) US20080138443A1 (enExample)
EP (1) EP1858504B1 (enExample)
JP (2) JP4717110B2 (enExample)
KR (1) KR101324920B1 (enExample)
AR (1) AR054015A1 (enExample)
AT (1) ATE539742T1 (enExample)
CA (1) CA2599252C (enExample)
CY (1) CY1112794T1 (enExample)
DK (1) DK1858504T3 (enExample)
ES (1) ES2380168T3 (enExample)
HR (1) HRP20120177T1 (enExample)
ME (1) ME02948B (enExample)
MX (1) MX2007010814A (enExample)
PL (1) PL1858504T3 (enExample)
PT (1) PT1858504E (enExample)
RS (1) RS52237B (enExample)
SI (1) SI1858504T1 (enExample)
TW (1) TWI388318B (enExample)
WO (1) WO2006094900A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
WO2018031922A1 (en) * 2016-08-11 2018-02-15 Sulfilatec, Inc. Medical and nutritional compositions and methods of use
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) * 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
US6537976B1 (en) 1997-08-07 2003-03-25 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
KR100642731B1 (ko) * 1999-10-11 2006-11-03 시그마타우 인두스트리에 파르마슈티케 리우니테 에스.피.에이. 의료용 용액에서 삼투제로서 l-카르니틴 및 그의알카노일 유도체의 용도
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
CA2508596A1 (en) 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Lカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
RS52237B (sr) 2012-10-31
DK1858504T3 (da) 2012-04-30
PT1858504E (pt) 2012-04-10
CA2599252C (en) 2013-07-30
SI1858504T1 (sl) 2012-04-30
JP2010207630A (ja) 2010-09-24
CA2599252A1 (en) 2006-09-14
TW200714279A (en) 2007-04-16
KR20070116630A (ko) 2007-12-10
EP1858504A1 (en) 2007-11-28
ES2380168T3 (es) 2012-05-09
WO2006094900A1 (en) 2006-09-14
US20080138443A1 (en) 2008-06-12
ATE539742T1 (de) 2012-01-15
MX2007010814A (es) 2007-11-07
EP1858504B1 (en) 2012-01-04
PL1858504T3 (pl) 2012-05-31
KR101324920B1 (ko) 2013-11-01
HRP20120177T1 (hr) 2012-03-31
AR054015A1 (es) 2007-05-30
CY1112794T1 (el) 2016-02-10
JP2008532601A (ja) 2008-08-21
ME02948B (me) 2012-10-31
JP5366894B2 (ja) 2013-12-11
TWI388318B (zh) 2013-03-11

Similar Documents

Publication Publication Date Title
Kletzmayr et al. Anemia and carnitine supplementation in hemodialyzed patients
AU2010234206B2 (en) Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds
JP6771191B2 (ja) 腎不全患者治療のためのカルボン酸混合物
JPH06199663A (ja) 精神分裂病治療法
CN103533833A (zh) 降脂抗糖尿病剂
EA013846B1 (ru) Фармацевтическая композиция, содержащая лактат, и ее применение
CN101795681B (zh) 预防肾钙质沉着的方法
JPH08319242A (ja) 肺疾患処置用医薬組成物
JP5366894B2 (ja) 生体適合性が改善されたカルニチンを含有する腹膜透析液
KR20020038809A (ko) 의료용 용액에서 삼투제로서 l-카르니틴 및 그의알카노일 유도체의 용도
JPWO2008123298A1 (ja) 癌患者用輸液製剤
JP3182564B2 (ja) 栄養組成物
Kimura et al. Platelet protein kinase C isoform content in type 2 diabetes complicated with retinopathy and nephropathy
JP5847712B2 (ja) クレアチン化合物の投与による透析患者の細胞保護
WO2019035989A1 (en) PREVENTION OF CALCIUM OXALATE RENAL CALCULATIONS BY POTASSIUM HYDROXYCITRATE
TW201500042A (zh) 與血液透析有關的低血壓的治療
MXPA02000912A (es) Uso de l-carnitina y sus derivados alcanoilo para la preparacion de un medicamento util para el tratamiento de pacientes que sufren nefropatias diabeticas o por insuficiencia metabolica.
US11964087B2 (en) Peritoneal dialysis solution
JP6811983B2 (ja) 網膜神経節細胞死抑制活性を有する経口用組成物
JP2009084211A (ja) 神経細胞賦活組成物
EP4561559A1 (en) Catechin containing formulations for use in treating diabetic cardiomyopathy
WO2011083490A2 (en) Stable veterinary composition for enhanced phosphorous uptake
WO2020210608A1 (en) Liquid concentrates of calcium and magnesium
Deshpande A 58 year old man with bleeding oesophageal varices who became hyponatraemic with renal replacement therapy
JP2008133271A (ja) 生活習慣病の予防および/または治療用組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090219

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100126

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20100128

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100426

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100507

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100524

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100531

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100907

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101207

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110308

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110329

R150 Certificate of patent or registration of utility model

Ref document number: 4717110

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140408

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250